Data / Form D filings / Esanik Therapeutics, Inc.
Esanik Therapeutics, Inc.: Form D filings
Esanik Therapeutics, Inc., a pharmaceuticals company in Northville, MI, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on April 30, 2026, reports $200,000 sold of a $375,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 120 West Main Street, Northville, MI, 48167
- Phone
- (610) 725-1500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2044524
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | New notice | $375,000 | $200,000 | $175,000 | 1 | Apr 6, 2026 | sec.gov |
| Nov 14, 2024 | New notice | $3,278,915 | $3,278,915 | 4 | Oct 31, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Mel Sorensen | Executive Officer, Director |
Other pharmaceuticals companies in Michigan that filed recently
- IMACS Working Capital Facility One LLC $200,000 · Sep 17, 2026
Every Form D from the week of Apr 27, 2026 · All recent filings in Michigan · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Esanik Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.